RIA
AGIO icon

Realta Investment Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

Realta Investment Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-135
Closed -$4K – 1582
2019
Q3 		$4K Buy
+135
New +$5.59K ﹤0.01% 1356
2019
Q2 		– Sell
-585
Closed -$39K – 1693
2019
Q1 		$39K Buy
+585
New +$34.1K 0.02% 607

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Realta Investment Advisors's AGIO Position: Q4 2019 in Review

Realta Investment Advisors sold out of Agios Pharmaceuticals (AGIO) in Q4 2019, closing a stake of 135 shares — an estimated $4K sold.

Realta Investment Advisors first reported a position in AGIO in Q1 2019 and held it in 2 quarters. The position peaked at $39K in Q1 2019. 198 funds tracked by Wall St. Rank hold AGIO as of Q4 2019.

  • Realta Investment Advisors reported no remaining Agios Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Realta Investment Advisors sold 135 Agios Pharmaceuticals shares in Q4 2019, an estimated $4K.
  • Realta Investment Advisors first reported a position in Agios Pharmaceuticals in Q1 2019 and held it in 2 quarters.
  • Realta Investment Advisors's Agios Pharmaceuticals position peaked at $39K in Q1 2019.
  • 198 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2019.

Based on Realta Investment Advisors's 13F filing for Q4 2019, filed 5 Feb 2020.